US Broker Ratings

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a $14.48 Billion Market Cap Amidst Undefined Financial Metrics

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a trailblazing entity in the healthcare sector, specifically within the niche of Traditional Chinese medicine (TCM). Headquartered in Causeway Bay, Hong Kong, Regencell..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a Potential 17.90% Upside with Robust Growth Prospects

HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities sector, commands a market capitalization of $96.54 billion. The company, headquartered in Nashville, Tennessee, operates a vast network..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 45% Potential Upside in the Healthcare Sector

Doximity, Inc. (DOCS) stands out as a pivotal player in the health information services industry, leveraging its robust digital platform to transform the way medical professionals interact and manage their..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 260% Revenue Growth Amidst Valuation Challenges

Moderna, Inc. (NASDAQ: MRNA), a biotech giant renowned for its groundbreaking work in mRNA technology, is currently at a pivotal juncture. Despite achieving an impressive 260.20% revenue growth, the company’s..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 58.99% Potential Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a pivotal player in the healthcare sector’s health information services industry, is garnering significant attention from investors due to its robust market presence and promising..

Haleon plc (HLN) Stock Analysis: Potential 28.87% Upside Captures Investor Attention

Haleon plc (HLN), a prominent name in the healthcare sector, stands out in the drug manufacturing industry with a market cap of $40.43 billion. As a key player specializing in..

Royalty Pharma plc (RPRX) Stock Analysis: Healthcare Giant with a Promising 16.66% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique entity within the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $29.25 billion, it plays a pivotal..

Bruker Corporation (BRKR) Stock Analysis: Evaluating the 10.64% Upside Potential for Investors

Bruker Corporation (NASDAQ: BRKR) stands at the forefront of the medical devices industry within the healthcare sector, a critical player in scientific and diagnostic solutions. With a market capitalization of..

Nuvalent, Inc. (NUVL) Stock Analysis: 35% Potential Upside Amid Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the biotechnology industry with a market capitalization of $8.32 billion. Investors keen on the..

Becton, Dickinson (BDX) Stock Analysis: Uncovering a 22.66% Upside in the Healthcare Giant

Becton, Dickinson and Company (BDX), a stalwart in the healthcare sector, stands out as a pivotal player in the medical instruments and supplies industry. With a robust market capitalization of..

Centene Corporation (CNC) Stock Analysis: Navigating Revenue Growth and Market Positioning

As the healthcare industry continues to evolve, Centene Corporation (NYSE: CNC) stands out as a formidable player, particularly in the realm of managed care services. With a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Report: Analyst Ratings Suggest 24% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a burgeoning entity in the biotechnology sector, has captured investor attention with its promising pipeline of therapies aimed at unmet medical needs. Based in Hellerup,..

Gilead Sciences (GILD) Stock Analysis: A 20% Upside Potential Amid Robust Growth in Healthcare

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the biopharmaceutical industry. With a market capitalization of $163.06..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking a 67.83% Potential Upside for Biotech Investors

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, is capturing the interest of investors with its innovative approach in the healthcare industry. Headquartered in Miami, Florida,..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Frontier with Strong Revenue Growth and Strategic Partnerships

Illumina, Inc. (ILMN), a cornerstone in the healthcare sector, continues to captivate investors with its robust position in the diagnostics and research industry. With a market capitalization of $21.47 billion,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Strong Growth with 28.55% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is a standout player in the healthcare sector, with a focus on medical care facilities across the United States. With a robust market cap..

CVS Health Corporation (CVS) Stock Analysis: Navigating 10.69% Potential Upside in Healthcare Plans

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the healthcare plans industry. With a substantial market capitalization of..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Growth Potential and Strategic Insights Amid Market Fluctuations

Medpace Holdings, Inc. (NASDAQ: MEDP) has positioned itself as a formidable player within the Healthcare sector, specifically in the Diagnostics & Research industry. The company’s expansive footprint across North America,..

AptarGroup, Inc. (ATR) Stock Analysis: Evaluating a 34.96% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is a formidable player in the medical instruments and supplies industry, operating primarily within the healthcare sector. With its headquarters in Crystal Lake, Illinois, AptarGroup has..

Halozyme Therapeutics (HALO) Stock Analysis: Exploring a Promising 33.78% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is catching the eye of investors with a robust upside potential of 33.78%, according to recent analyst ratings. Specializing in biotechnology, the company is a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds